ArticleJapanese journal of ophthalmology2025
Midterm outcomes of Ahmed glaucoma valve implantation and trabeculectomy in exfoliative glaucoma.
Article in Japanese journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comparative In Vitro Evaluation of Tube Resistance in Glaucoma Drainage Devices with Intraluminal Polypropylene Threads.Bioengineering (Basel, Switzerland) · 2026Article
- Risk Factors for Postoperative Hyphema Following Baerveldt Glaucoma Implant Surgery: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Possible Effects of Topical Rho-Kinase Inhibitor on Schlemm's Canal Morphology Parameters.Biomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeTo report the midterm outcomes of Ahmed glaucoma valve (AGV) implantation and trabeculectomy (Trab) in exfoliative glaucoma (XFG). STUDY
designWe performed a retrospective comparison analysis of 95 eyes of 81 patients with AGV implantation versus 88 eyes of 82 patients with Trab for XFG up to 3 years.
methodThe intraocular pressure, number of medications, corneal endothelial cell numbers, and surgical complications were analyzed. The cumulative probability of success was analyzed by 5 ≦IOP ≦18 mm Hg and reduction of IOP ≧20% from the preoperative IOP. Kaplan-Meier survival analysis was used to analyze the probability of success and for the comparison between the Trab group and the AGV group.
resultsThe cumulative probability of the qualified surgical success rate was higher, but the complete success rate was lower in the AGV group than in the Trab group. AGV insertion for the eyes with a history of Trab failure and for the eyes without a history of previous glaucoma operations showed no significant difference in postoperative IOP. The occurrence of layered hyphema was higher in the AGV group, but the overall occurrence rates of other complications were similar in the 2 groups.
conclusionAGV implantation is a reasonable surgical method for XFG, especially for patients with a history of previously failed Trab.
Indexed as
Identifiers
40748551What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.